Glycemic Control and Adverse Clinical Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus: Results from KNOW-CKD

Glycemic Control and Adverse Clinical Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus: Results from KNOW-CKD

Background The optimal level of glycosylated hemoglobin (HbA1c) to prevent adverse clinical outcomes is unknown in patients with chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM). Methods We analyzed 707 patients with CKD G1-G5 without kidney replacement therapy and T2DM from the Kore...

Full description

Bibliographic Details
Main Authors: Ga Young Heo, Hee Byung Koh, Hyung Woo Kim, Jung Tak Park, Tae-Hyun Yoo, Shin-Wook Kang, Jayoun Kim, Soo Wan Kim, Yeong Hoon Kim, Su Ah Sung, Kook-Hwan Oh, Seung Hyeok Han
Format: Article
Language:English
Published: Korean Diabetes Association 2023-07-01
Series:Diabetes & Metabolism Journal
Subjects:
cardiovascular diseases
diabetes mellitus, type 2
glycated hemoglobin a
renal insufficiency, chronic
Online Access:http://e-dmj.org/upload/pdf/dmj-2022-0112.pdf

Internet

http://e-dmj.org/upload/pdf/dmj-2022-0112.pdf

Similar Items